Bone marrow biopsy response to imatinib mesylate in patients with MHES
. | Cellularity . | . | Reticulin staining* . | . | Atypical mast cells† . | . | |||
|---|---|---|---|---|---|---|---|---|---|
| Patient no. . | Before . | After . | Before . | After . | Before . | After . | |||
| 1 | 100 | 60 | 3 | Focal | + | - | |||
| 2 | 40 | 30 | 0 | 0 | + | - | |||
| 3 | 95 | 50 | 3 | 2 | + | - | |||
| 4 | 100 | 50 | 4 | 1 | + | - | |||
| 5 | 30 | 30 | 2 | 0 | + | - | |||
| 7 | 40 | 30 | 3 | 2 | + | - | |||
. | Cellularity . | . | Reticulin staining* . | . | Atypical mast cells† . | . | |||
|---|---|---|---|---|---|---|---|---|---|
| Patient no. . | Before . | After . | Before . | After . | Before . | After . | |||
| 1 | 100 | 60 | 3 | Focal | + | - | |||
| 2 | 40 | 30 | 0 | 0 | + | - | |||
| 3 | 95 | 50 | 3 | 2 | + | - | |||
| 4 | 100 | 50 | 4 | 1 | + | - | |||
| 5 | 30 | 30 | 2 | 0 | + | - | |||
| 7 | 40 | 30 | 3 | 2 | + | - | |||
Reticulin staining was graded on a scale of 0-4 with 0 indicating no staining present.
Detected by antitryptase antibody staining; + indicates increased mast cell numbers, with spindle-shaped mast cells representing ≥ 25% of mast cells present in marrow; and -, normal mast cell numbers and morphology.